1. Myofibroblast keratinocyte growth factor reduces tight junctional integrity and increases claudin-2 levels in polarized Caco-2 cells. Kim TI, Poulin EJ, Blask E, Bukhalid R, Whitehead RH, Franklin JL, Coffey RJ (2012) Growth Factors 30(5): 320-32
    › Primary publication · 22946653 (PubMed) · PMC3594790 (PubMed Central)
  2. Gastric tumor development in Smad3-deficient mice initiates from forestomach/glandular transition zone along the lesser curvature. Nam KT, O'Neal R, Lee YS, Lee YC, Coffey RJ, Goldenring JR (2012) Lab Invest 92(6): 883-95
    › Primary publication · 22411066 (PubMed) · PMC3584162 (PubMed Central)
  3. Enterocyte microvillus-derived vesicles detoxify bacterial products and regulate epithelial-microbial interactions. Shifrin DA, McConnell RE, Nambiar R, Higginbotham JN, Coffey RJ, Tyska MJ (2012) Curr Biol 22(7): 627-31
    › Primary publication · 22386311 (PubMed) · PMC3326206 (PubMed Central)
  4. [18F]FLT-PET to predict pharmacodynamic and clinical response to cetuximab therapy in Ménétrier's disease. McKinley ET, Smith RA, Tanksley JP, Washington MK, Walker R, Coffey RJ, Manning HC (2012) Ann Nucl Med 26(9): 757-63
    › Primary publication · 22821337 (PubMed) · PMC3543701 (PubMed Central)
  5. Resistance to EGFR-targeted therapy: a family affair. Vlacich G, Coffey RJ (2011) Cancer Cell 20(4): 423-5
    › Primary publication · 22014569 (PubMed) · PMC3616495 (PubMed Central)
  6. Naked1 antagonizes Wnt signaling by preventing nuclear accumulation of β-catenin. Van Raay TJ, Fortino NJ, Miller BW, Ma H, Lau G, Li C, Franklin JL, Attisano L, Solnica-Krezel L, Coffey RJ (2011) PLoS One 6(4): e18650
    › Primary publication · 21490931 (PubMed) · PMC3072412 (PubMed Central)
  7. Identification of a novel mono-leucine basolateral sorting motif within the cytoplasmic domain of amphiregulin. Gephart JD, Singh B, Higginbotham JN, Franklin JL, Gonzalez A, Fölsch H, Coffey RJ (2011) Traffic 12(12): 1793-804
    › Primary publication · 21917092 (PubMed) · PMC3886124 (PubMed Central)
  8. Dual blockade of the EGFR and COX-2 pathways: a phase II trial of cetuximab and celecoxib in patients with chemotherapy refractory metastatic colorectal cancer. Chan E, Lafleur B, Rothenberg ML, Merchant N, Lockhart AC, Trivedi B, Chung CH, Coffey RJ, Berlin JD (2011) Am J Clin Oncol 34(6): 581-6
    › Primary publication · 21217396 (PubMed) · PMC3133812 (PubMed Central)
  9. A novel in vitro assay to assess phosphorylation of 3'-[(18)F]fluoro-3'-deoxythymidine. Guo N, Xie J, Manning HC, Deane NG, Ansari MS, Coffey RJ, Gore J, Price RR, Baldwin RM, McIntyre JO (2011) Mol Imaging Biol 13(2): 257-64
    › Primary publication · 20532643 (PubMed) · PMC4180216 (PubMed Central)
  10. Amphiregulin exosomes increase cancer cell invasion. Higginbotham JN, Demory Beckler M, Gephart JD, Franklin JL, Bogatcheva G, Kremers GJ, Piston DW, Ayers GD, McConnell RE, Tyska MJ, Coffey RJ (2011) Curr Biol 21(9): 779-86
    › Primary publication · 21514161 (PubMed) · PMC3417320 (PubMed Central)